
Battery Ventures carves out UK-based TTP Labtech
US VC Battery Ventures has acquired TTP Labtech, the biotech arm of TTP Group.
Following the investment, TTP Labtech will look to make strategic acquisitions and develop new products. It will continue to manufacture its products in the UK and look to expand its operations in Cambridge.
The VC closed Battery Ventures XII on $800m in February.
Company
Founded in 1997 and based in Cambridge, UK, TTP Labtech produces products that improve workflows within drug discovery, structural biology, molecular biology and genomics.
In the year to 31 March 2018, it generated turnover of £24.4m and made a small operating loss. Its biggest market is North America and it employs 130 staff.
People
Battery Ventures – Jesse Feldman (partner).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater